IT1274592B - Composizione farmaceutica per la terapia tumorale contenente xenoantigeni - Google Patents

Composizione farmaceutica per la terapia tumorale contenente xenoantigeni

Info

Publication number
IT1274592B
IT1274592B ITMI941713A ITMI941713A IT1274592B IT 1274592 B IT1274592 B IT 1274592B IT MI941713 A ITMI941713 A IT MI941713A IT MI941713 A ITMI941713 A IT MI941713A IT 1274592 B IT1274592 B IT 1274592B
Authority
IT
Italy
Prior art keywords
xenoantigens
pharmaceutical composition
cancer therapy
therapy containing
hclo41n
Prior art date
Application number
ITMI941713A
Other languages
English (en)
Inventor
Angela Turiano
Original Assignee
Angela Turiano
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angela Turiano filed Critical Angela Turiano
Publication of ITMI941713A0 publication Critical patent/ITMI941713A0/it
Priority to ITMI941713A priority Critical patent/IT1274592B/it
Priority to US08/817,595 priority patent/US20030045453A1/en
Priority to ES95904529T priority patent/ES2285702T3/es
Priority to DK95904529T priority patent/DK0773789T3/da
Priority to DE69434946T priority patent/DE69434946T2/de
Priority to EP95904529A priority patent/EP0773789B1/en
Priority to PT95904529T priority patent/PT773789E/pt
Priority to PCT/EP1994/004290 priority patent/WO1996004005A1/en
Priority to AT95904529T priority patent/ATE357926T1/de
Publication of ITMI941713A1 publication Critical patent/ITMI941713A1/it
Application granted granted Critical
Publication of IT1274592B publication Critical patent/IT1274592B/it
Priority to US11/107,782 priority patent/US20050238653A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

si descrivono xenoantigeni scelti fra le molecole di istocompatibilità ottenibili per estrazione da omogenati di tessuti o cellule con detergente Nonidet P40 o con acido HCLO41N, per l'uso come medicamento per la stimolazione del sistema immunitario dell'uomo e dei mammiferi, ed in particolare per la terapia tumorale.(fig. 2).
ITMI941713A 1994-08-05 1994-08-05 Composizione farmaceutica per la terapia tumorale contenente xenoantigeni IT1274592B (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
ITMI941713A IT1274592B (it) 1994-08-05 1994-08-05 Composizione farmaceutica per la terapia tumorale contenente xenoantigeni
DE69434946T DE69434946T2 (de) 1994-08-05 1994-12-22 Verwendung von Haupthistokompatibilitätskomplex (MHC)-Xenoantigenen bei der Herstellung eines Medikamentes für eine therapeutische Behandlung von Krebs
ES95904529T ES2285702T3 (es) 1994-08-05 1994-12-22 Uso de xenoantigeno mhc en la fabricacion de medicamento para el tratamiento de cancer.
DK95904529T DK0773789T3 (da) 1994-08-05 1994-12-22 Anvendelse af MHC-xenoantigener til fremstilling af et medikament til cancerbehandling
US08/817,595 US20030045453A1 (en) 1994-08-05 1994-12-22 Pharmaceutical composition for stimulation of the immune system
EP95904529A EP0773789B1 (en) 1994-08-05 1994-12-22 Use of MHC xenoantigen in the manufacture of a medicament for the treatment of cancer
PT95904529T PT773789E (pt) 1994-08-05 1994-12-22 Composições farmacêuticas contendo moléculas de mhc extraidas para estimular o sistema imunitário
PCT/EP1994/004290 WO1996004005A1 (en) 1994-08-05 1994-12-22 Pharmaceutical compositions containing extracted mhc molecules, for stimulation of the immune system
AT95904529T ATE357926T1 (de) 1994-08-05 1994-12-22 Verwendung von mhc-xenoantigenes zur herstellung eines arzneimittels für eine therapeutische behandlung von krebs
US11/107,782 US20050238653A1 (en) 1994-08-05 2005-04-18 Pharmaceutical compositions containing extracted MHC molecules, for stimulation of the immune system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI941713A IT1274592B (it) 1994-08-05 1994-08-05 Composizione farmaceutica per la terapia tumorale contenente xenoantigeni

Publications (3)

Publication Number Publication Date
ITMI941713A0 ITMI941713A0 (it) 1994-08-05
ITMI941713A1 ITMI941713A1 (it) 1996-02-05
IT1274592B true IT1274592B (it) 1997-07-18

Family

ID=11369459

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI941713A IT1274592B (it) 1994-08-05 1994-08-05 Composizione farmaceutica per la terapia tumorale contenente xenoantigeni

Country Status (9)

Country Link
US (2) US20030045453A1 (it)
EP (1) EP0773789B1 (it)
AT (1) ATE357926T1 (it)
DE (1) DE69434946T2 (it)
DK (1) DK0773789T3 (it)
ES (1) ES2285702T3 (it)
IT (1) IT1274592B (it)
PT (1) PT773789E (it)
WO (1) WO1996004005A1 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2172322C1 (ru) 1999-12-27 2001-08-20 Энтофарм Ко., Лтд. Аллофероны-иммуномодулирующие пептиды

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9201023D0 (en) * 1992-01-17 1992-03-11 Medical Res Council Vaccines
JPH05246889A (ja) * 1992-03-05 1993-09-24 Seitai Chiyousetsu Kenkyusho:Kk 制癌方法および制癌剤
EP0569678A3 (en) * 1992-03-13 1994-10-26 Yeda Res & Dev Double transfectants of MHC genes as cellular vaccines for immunoprevention of tumor metastasis.
GB9214871D0 (en) * 1992-07-13 1992-08-26 Medical Res Council Vaccines
AU5872594A (en) * 1992-12-17 1994-07-04 Bishwajit Nag Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease

Also Published As

Publication number Publication date
PT773789E (pt) 2007-04-30
EP0773789B1 (en) 2007-03-28
ITMI941713A0 (it) 1994-08-05
DE69434946T2 (de) 2007-12-06
ES2285702T3 (es) 2007-11-16
US20050238653A1 (en) 2005-10-27
ITMI941713A1 (it) 1996-02-05
EP0773789A1 (en) 1997-05-21
DE69434946D1 (de) 2007-05-10
DK0773789T3 (da) 2007-05-29
ATE357926T1 (de) 2007-04-15
US20030045453A1 (en) 2003-03-06
WO1996004005A1 (en) 1996-02-15

Similar Documents

Publication Publication Date Title
EP0654973A4 (en) LYPHATIC TISSUE DRUG ADMINISTRATION SYSTEM.
HK1097449A1 (en) Methods for in vivo delivery of biologics and compositions useful therefor
ES8802055A1 (es) Procedimiento para la fabricacion de derivados gangliosidos
ATE219363T1 (de) Lösliche prodrugs von paclitaxel
AP9801392A0 (en) Concentrated antibody preparation.
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
DE69426334T2 (de) Parenterales Busulfan zur Behandlung von malignen Krankheiten
UA29466C2 (uk) Фармацевтична композиція з антипухлинною активністю
DK360188A (da) Laegemiddelafgivelsesorgan
IL146125A0 (en) Novel quinones as disease therapies
DK528988D0 (da) Laegemiddelafgivelsessystem
EP0305117A3 (en) 2',3'-dideoxy-3'-fluorothymidine and related compounds for the treatment of adenovirus infections
TW261615B (it)
IT8720181A0 (it) Composizioni farmaceutiche contenenti alcoli superiori per il trattamento di patologie della prostata.
ZA943553B (en) Tri(platinum) complexes
IT8920898A0 (it) Uso di sucralfato gel umido per il trattamento di ulcere del derma e come veicolo di farmaci ad attivita' topica.
PL315127A1 (en) Deuterised biologically active substances for percutaneous administration
IT1274592B (it) Composizione farmaceutica per la terapia tumorale contenente xenoantigeni
IT1255241B (it) Derivato di acido biliare e suo uso in terapia
UA27099C2 (uk) Склад для протипухлиhhої терапії у формі розчиhу, спосіб його одержаhhя та лікарський засіб для протипухлиhhої терапії
MD457G2 (ro) Derivaţi noi de naftiridină, procedeu de preparare a lor, compoziţii farmaceutice care le conţin, utilizarea lor ca medicamente de antireproducere
IT8722647A0 (it) Composizione farmaceutica per somministrazione nasale.
ATE211489T1 (de) Chitosan enthaltende zusammensetzung
ES8704903A1 (es) Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido.
WO1996036354A3 (en) Anticancer vaccine comprising il6/il6 receptor transfected cells

Legal Events

Date Code Title Description
0001 Granted